Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin K Reversal of INR for Perioperative Management of Warfarin
NCT07515664Phase 4Recruiting
- Sponsor
- University of Michigan
- Start
- Jul 2025
- Primary completion
- Aug 2026
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of phytomenadione, warfarin in warfarin-induced coagulopathy, sponsored by University of Michigan. Started Jul 2025; status: recruiting.
02
Drugs
phytomenadionewarfarin
03
Conditions
warfarin-induced coagulopathy
Beyond the preview
Go deeper on NCT07515664.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07515664.